Orin Hirschman, Director at Ohr Pharmaceutical Inc (OHRP), bought 342,858 shares at $0.70 ($240K) on 2017-04-10, disclosed to the SEC on 2017-12-06.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $0.70 | 171,429 | $120K | 50.0% |
| 2 | $0.70 | 171,429 | $120K | 50.0% |
| Total | $0.70 avg | 342,858 | $240K | 100% |